A joint study conducted by UPM Raflatac and Corning Pharmaceutical Technologies has revealed the sustainability and ...

Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...

If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in ...

Women’s health champions like us cheered in January when the U.S. Preventive Services Task Force (USPSTF) issued a draft ...

An injectable blood pressure drug has been recalled after the FDA has warned it could cause side effects, such as stroke or death.

The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.

Medicine may not be an exact science, but precision is crucial for patient care. That’s why the presence of unknown particles ...

The woman prescribed the drug through a Facebook group, according to the U.S. Attorney's Office District of Oregon.

The FDA says administering a drug containing particulate matter may cause local irritation or swelling. If the particulates enter blood vessels, it can travel to various organs and potentially ...

Collegeville, Pennsylvania, Provepharm Inc. is voluntarily recalling lot number 24020027; Expiry Date December 2025 of ...

Pennsylvania-based pharmaceutical firm Provepharm Inc is voluntarily recalling vials of phenylephrine hydrochloride, which is ...

Provepharm is recalling lot number 24020027; Expiry Date December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/ ...